Physician profile
Eugene P Wang
NPI 1922063908
$8,675.13
in general payments reported to CMS, 2019-2025
38 companies · $2,187 in 2025
The $2,187 reported for 2025 was more than what 94% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $956 · 2020: $933 · 2021: $996 · 2022: $1,273 · 2023: $997 · 2024: $1,334 · 2025: $2,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,001 · Travel and Lodging: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,001.48 |
| Travel and Lodging | $516.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,679.79 | 2019-2024 | Senza |
| Abbvie INC. | $1,500.60 | 2021-2025 | Botox, Mavyret, Ubrelvy |
| Biotronik Nro, INC. | $822.72 | 2023-2025 | Prospera, Biotronik |
| Globus Medical, INC. | $682.27 | 2025 | Senza |
| Amgen INC. | $603.03 | 2019-2024 | Evenity, Prolia |
| Medtronic, INC. | $390.00 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Collegium Pharmaceutical, INC. | $264.59 | 2019-2021 | |
| Boston Scientific Corporation | $257.53 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Bioness INC | $238.14 | 2020 | |
| Si-Bone, INC. | $235.65 | 2019-2024 | |
| Abbott Laboratories | $202.50 | 2022-2025 | Proclaim |
| Merz Pharmaceuticals, LLC | $189.08 | 2024-2025 | Xeomin, Inbrija |
| Stryker Corporation | $180.65 | 2022-2025 | Mild Device Kit, Spinejack |
| Allergan, INC. | $175.04 | 2019-2022 | |
| Vertos Medical, INC. | $163.12 | 2024 | Mild Device Kit |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.